Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

AsclepiX Therapeutics
301 W 29th Street, Suite 2004
Baltimore, MD 21211
Phone: 610-212-1217
https://asclepix.com/

AsclepiX Therapeutics Inc. is a biopharmaceutical company using computational biology to identify potent peptide regulators of vascular homeostasis that is disrupted in retinal and oncologic diseases. The novel clinical candidate peptides discovered by AsclepiX tap into these naturally existing self-regulating mechanisms, evolved over millions of years, that the body uses to maintain homeostasis and thus restore and maintain health. AXT107, an investigational product and the lead clinical candidate, has a unique mechanism of action that targets two clinically proven pathways of diseases of the retina. AXT107 is poised to enter the clinic in late 2020.

Key Contact
Name
Steven M. Altschuler
Title
Chairman
E-Mail
Funding Events

Date
Amount
Type
Investors
06/24/20 $35,000,000 Series A Barer & Son Capital
Perceptive Advisors
Rapha Capital Management